Vivacta Biotechnology (Shanghai) Co., Ltd.
PrivateLast Round
Series A
Apr 29, 2026
Total Funding Raised
$50M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vivacta Biotechnology (Shanghai) Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in April 2026.
Vivacta Biotechnology (Shanghai) Co., Ltd. is a biotechnology company developing in vivo CAR-T therapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivacta Biotechnology (Shanghai) Co., Ltd. Comparables
Compare Vivacta Biotechnology (Shanghai) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grit Biotherapeutics | 59% | |
| Gilead Sciences | 57% | |
| CREATE Medicines | 55% |
For institutional investors. Book with your work email.
Vivacta Biotechnology (Shanghai) Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Vivacta Biotechnology (Shanghai) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series A |
| Eisai Innovation | Series A |
| OrbiMed | Series A |
| Xiamen C&D Emerging Industry Equity Investment | Series A |
| Beijing Shunxi Fund | Series A |
| Hankang Capital | Series A |
| Qiming Venture Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
$50M round led by Decheng Capital.
For institutional investors. Book with your work email.
Vivacta Biotechnology (Shanghai) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivacta Biotechnology (Shanghai) Co., Ltd.'s valuation, stock price, and market status.
Is Vivacta Biotechnology (Shanghai) Co., Ltd. a public or private company?
Vivacta Biotechnology (Shanghai) Co., Ltd. is a private company.
What is the current stock price of Vivacta Biotechnology (Shanghai) Co., Ltd.?
Vivacta Biotechnology (Shanghai) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Vivacta Biotechnology (Shanghai) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivacta Biotechnology (Shanghai) Co., Ltd. worth (valuation)?
Valuation information for Vivacta Biotechnology (Shanghai) Co., Ltd. is not publicly available.
Can I buy Vivacta Biotechnology (Shanghai) Co., Ltd. stock?
Vivacta Biotechnology (Shanghai) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivacta Biotechnology (Shanghai) Co., Ltd.'s last funding round?
Vivacta Biotechnology (Shanghai) Co., Ltd.'s most recent funding round was Series A on April 29, 2026.
Who are the main investors in Vivacta Biotechnology (Shanghai) Co., Ltd.?
Key investors in Vivacta Biotechnology (Shanghai) Co., Ltd. include Loyal Valley Capital, Decheng Capital.
Will Vivacta Biotechnology (Shanghai) Co., Ltd. IPO soon?
No public IPO plans have been announced for Vivacta Biotechnology (Shanghai) Co., Ltd..
How can I track Vivacta Biotechnology (Shanghai) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Vivacta Biotechnology (Shanghai) Co., Ltd.'s shares on secondary markets.